Rapid HTAs of five medical devices released in Tuscany

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Below is the list of technologies that have been assessed:

• TYRX™ Absorbable Antibacterial Envelope for implantable cardiac pacemaker and defibrillator;
• Figulla® Flex II patent foramen ovale occluder;
• AMDS system, a hybrid system for aortic dissection;
• ClariVein System for varicose vein treatment;
• Taurolock U-25000 antimicrobial catheter lock solution.

See the regional decree and all assessments in Italian here or here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.